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Abstract
Objectives: Several inconsistent studies have investigated whether the uterine environment of androgenized
pregnant women is a risk factor for an in-utero developmental imprinted predisposition towards subsequent
polycystic ovarian syndrome (PCOS) among their female offspring. These are difficult to compare due to variable
parameters and subject selection criteria. Few epidemiological studies have analyzed the incidence of PCOS
amongst adult daughters of PCOS affected women previously. Our study aimed to investigate risk factors relating to
the development of PCOS in the female offspring of PCOS patients.
Methods: We used a questionnaire to collect a mother-to-daughter medical history and relevant information, in
order to understand risk factors, which might relate to the presence of PCOS daughters of PCOS patients.
Results: Of four hundred and one responses, 131 participants were included in the final analysis. There was no
statistical association with the subsequent development of PCOS amongst female offspring of women with PCOS.
However, there was a significantly higher prevalence of post-term birth among PCOS mothers. Nevertheless, the
major determinant of risk of subsequent incidence of PCOS amongst daughters was a higher BMI, regardless of the
mothers BMI.
Conclusion: Socio-economic family influences, affecting BMI, may be the reason for any mother to daughter
association with PCOS.
Keywords: Androgenism; Body mass index; Online questionnaire;
Polycystic ovarian syndrome; Term of labour
Introduction
Polycystic ovary syndrome is a frequent female endocrinopathy,
estimated to affect  at least five percent of women during their
reproductive age [1]. However, some women do not display all of the
diagnostic symptoms and/or do not seek medical help, so the
prevalence of PCOS may even be as high as 20% [2]. The syndrome
was initially described in the 1930s by Stein and Leventhal as cystic
ovaries, menstrual irregularities, hirsutism, and obesity [3]. Due to its
heterogeneous nature, the exact diagnostic criteria has always been
difficult and in 2003, PCOS diagnostic criteria were defined as the
presence of two out of three features (after the exclusion of other
pathologies); oligomenorrhoea and/or anovulation; clinical and/or
biochemical hyperandrogenism; and polycystic ovaries [4]. 
The development of PCOS is believed to be highly influenced by
environmental factors including obesity, unhealthy diet, sedentary
lifestyle, inflammatory processes and infectious agents and toxins [5,6].
Furthermore, the intrauterine environment may play an important role
in the aetiology of PCOS: Both animal-based models and human
clinical studies, indicate a connection between the exposure of the
fetus to elevated androgen levels in utero and the occurrence of PCOS
or PCOS-associated features in childhood, adolescence and adult life
[7-10]: Prenatally androgenized female rodents have shown altered
regulation of Gonadotropin Releasing Hormone (GnRH) neurons [7,8]
and the exposure of sheep to androgens in their mid-pregnancy
resulted in the reduction of the GnRH network efficiency [7].
Rhesus monkeys, subjected to androgens during pregnancy,
demonstrated multi-follicular ovaries and reduced menstrual
periodicity in adult life [9]. In utero, androgen, exposed animals
expressed variable features of the PCOS phenotypes in adult life,
depending on the time and level of exposure to androgens. Although
not proven statistically, this subjectively association of an epigenetic
familial trend could bring us closer to the understanding of the
diversity of PCOS phenotypes and its molecular pathology. In humans,
the fetus is protected against excesses of maternal testosterone by
placental aromatase – that converts androgens into estrogens [7].
However, as with all biological controls, placental aromatase maybe
functionally compromised and fetal androgen exposure ensues. Factors
contributing to a placental failure to mount an effective barrier are:
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aromatase deficiency [11], stress [9], and high insulin concentrations
[12].
It has been demonstrated that women born after term, or born to
malnourished mothers, showed high luteinizing hormone (LH) serum
levels in adulthood [10]. Although at the very bottom end of the PCOS
phenotypic spectrum, this may indicate circumstances that enable
androgens to surpass natural protective mechanisms and presumably
set hypothalamic responses in the developing fetus to be more
androgenic. Applying this reasoning further, high testosterone levels in
pregnant women with PCOS, together with insulin resistance (which is
frequently a co-feature of the syndrome), may provide suitable
conditions allowing for fetal androgen exposure and hence predispose
female offspring to developing PCOS in adult life.
Given the capacity of body fat tissue aromatase to convert estrogens
to testosterone several studies have tried to find an association between
obesity, high birth weight, and the subsequent development of PCOS
by female offspring. Two previous studies reported that birth weight
from infants born to PCOS-affected mothers were significantly lower
in comparison of the control group [13,14]. However, the opposite
findings have also been reported [15].
The question of whether or not there is any relationship between
birth weight and PCOS in adult life has also been addressed: There are
two distinct patterns reported in the literature: (1) a higher incidence
of polycystic ovaries among overweight women who were born large
for gestational age to obese mothers; and (2) high incidence of PCOS
among lean women who were born after term [10].
In this study, the self-reported mother/daughter medical history of
four hundred and one cases were collected and after applying rigorous
exclusion criteria 131 were analyzed in order to examine any
relationship between maternal PCOS and PCOS among their adult
daughters. Furthermore, the prevalence of the syndrome with regards
to the birth weight and pre-term or post term delivery was also
investigated.
Methods
An online questionnaire was developed and placed on PCOS related
websites and online forums including Polycystic Ovary Syndrome
(PCOS) (available at: https://www.facebook.com/PCOSstrong), PCOS
Research (available at: https://www.facebook.com/PCOSResearch),
PCOS Awareness Association (available at: https://www.facebook.com/
PCOSAwarenessAssociation), PCOS Diva (available at: https://
www.facebook.com/pcosdiva), and PCOS (available at: https://
www.facebook.com/HealthySmartsMD). Links to the survey were
published on these websites from which an administrators’ agreement
was received.
The questionnaire consisted of three parts: (1) questions about the
participant (mother); (2) questions about the pregnancy; (3) questions
about the daughter. (see supplemental data). Responses received within
48 hours (between the 15th and 17th February 2014) were collected.
Questionnaires were vetted for final data analysis and excluded on
the basis of:
1) Sections Incomplete.
2) Other prevailing medical conditions self-reported.
3) Medication taken during pregnancy.
4) Alcohol consumption taken during the pregnancy.
5) Maternal age did not exceed 30 years.
6) Daughters at time of completion of questionnaire were 18 or over
years of age.
7) Those self-reporting symptoms of PCOS but not reporting having
been clinically diagnosed with PCOS.
In the analysis PCOS was defined in daughter as those reporting
having been diagnosed with PCOS.
Ethics and data protection
Ethical approval was obtained from the Middlesex University,
School of Health & Social Sciences, Natural Sciences Ethics sub-
Committee. An anonymous online questionnaire, and participant
consents was implicit in its completion.
Data analysis
The data were analyzed using Minitab software version 16. Chi-
Square analysis was performed on categorical data, Two-sample T-tests
on continuous numerical data (following positive variance and
normality test results) and Mann-Whitney test on non-parametric data
with the level of significance set at 0.05 and correlation interval (CI) of
95%.
Results
Within the two-day period in which the survey was run, 401
responses were received. 155 were excluded as the response
questionnaire was missing crucial data (daughter's age, PCOS status,
risk behaviors during the pregnancy); 115 were excluded for failing one
or more of the other exclusion criteria (Figure 1).
Figure 1: A flow chart to illustrate the patients’ profiles during the
selection process.
Statistical analysis of responses was based on 131 respondent pairs
(32.7% of the initial number). Within this cohort, 22 mothers (16.8%)
and 99 (75.6%) of daughters were diagnosed with PCOS; 109 (83.2%)
mothers and 32 (24.4%) daughters did not have PCOS.
Of the 22 mothers with PCOS, 16 women (72.7% of the group)
reported daughters with a diagnosis of PCOS and 6 (27.3%) PCOS
affected mothers reported daughters without a diagnosis of PCOS.
Conversely, of the 109 mothers without PCOS, 26 (23.9%) of their
daughters were also unaffected by PCOS, but 83 (76.1%) had
developed PCOS (Figure 1).
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Maternal weight status before the pregnancy
Maternal weight status PCOS Daughters Non-PCOS Daughters
Underweight** 8 (8.1) 4 (12.5)
Normal** 71 (71.7) 25 (78.1)
Overweight** 20 (20.2) 3 (9.38)
Women's birth weight in relation to their PCOS status (born in term only)
PCOS Women Non-PCOS Women
N 80 62
Birth Weight (g)* 3420 (± 516) 3305 (± 550)
PCOS among mothers in relation to their daughters' PCOS status
PCOS Daughters Non-PCOS Daughters
PCOS Mothers** 16 (16.2) 6 (18.8)
Non-PCOS Mothers** 83 (83.8) 26 (81.2)
Daughters' BMI in relation to maternal PCOS status
PCOS Mothers Non-PCOS Mothers
N 21 100
Daughter's BMI* 28.46 (± 8.18) 32.93 (± 9.82)
Daughters' BMI in relation to their PCOS status
PCOS Daughters Non-PCOS Daughters
N 90 31
Daughters' BMI* 34.59 (±9.35) 25.08 (±6.74)
Daughters' birth weight in relation to maternal PCOS status
PCOS Mothers Non-PCOS Mothers
N 20 107
Daughters' Birth Weight (g)* 3303 (±489) 3333 (±634)
Women's birth term in relation to their PCOS status
Birth term PCOS Women Non-PCOS Women
Before term** 13 (11.3) 17 (14.4)
In term** 84 (73.0) 92 (78.0)
After term** 18 (15.7) 9 (7.6)
The prevalence of post-term birth among women in regard to their PCOS
status
Birth term PCOS Women Non-PCOS Women
Before/In term** 96 (83.5) 109 (92.4)
After Term** 19 (16.5) 9 (7.6)
*mean (±SD); ** n (%)
Table 1: Analysis of the potential risk factors in relation to PCOS
status.
Maternal age at the time of giving birth was compared between both
groups and no significant difference was found, ensuring at the same
time that samples are representative. Groups were also similar in terms
of risk behaviors during the pregnancy (smoking, stress). The mean
age of all reported daughters was 29.4 (±6.4) years [25.9 (±5.7) years
for healthy daughters and 30.5 (±6.2) for PCOS diagnosed daughters].
No significant differences were found in terms of their birth weights
between PCOS and non-PCOS women. Also, no correlation was
observed between whether they were diagnosed as PCOS and their
birth term (before term, in term or after term); however there was a
significant difference in the prevalence of the history of post-term birth
among PCOS women in comparison to the control group (Table 1 and
Figure 2).
Figure 2: Comparison of the birth terms of the PCOS and non-
PCOS women. The percentage prevalence of pre-term birth (dotted
areas) was significantly higher in PCOS group (16.5%) than in
group of women not diagnosed with PCOS (7.6%).
Figure 3: The difference in the BMI between PCOS and non-PCOS
daughters. The mean BMI of PCOS affected daughters was 34.59
(±9.35). The mean BMI of non-PCOS daughters was 25.08 (±6.74).
P-value (Mann-Whitney Test): <0.001.
Among the diagnosed mothers, only two (12.5%) were born after
term. No significant differences were found between maternal birth
weights in relation to their PCOS status. Based on the Chi-Square
analysis, none of these factors, which are maternal body weight; the
term of delivery for the baby and maternal PCOS status, has been
found to correlate with their likelihood of giving birth to a daughter
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who will develop into PCOS at later stage. PCOS daughters were found
to have significantly higher body mass index (BMI), however their
BMIs were not associated with their mothers' PCOS status nor with
their own birth weight (Table 1 and Figure 3).
Discussion
There are no substantive epidemiological or prospective studies,
which report a statistical prevalence of PCOS among adult daughters
of PCOS women; although many have suggested a link. These studies
reported the incidence of only one of the syndrome's indications
[16,17] or were based on the analysis of relatively young daughters
[18,19] where the unequivocal diagnosis of PCOS was not established.
This study directly addressed the question of a link between diagnosed
maternal PCOS and subsequent development of diagnosed PCOS in
female offspring.
Although it possesses certain advantages (relatively large sample
size, demanding inclusion criteria, and the analysis of adult daughters),
it also has its limitations, in that the accuracy of the data collected
could not be verified. Indeed, although applying a strict inclusion
criteria we almost certainly only selected firmly clinically diagnosed
PCOS patients; (32.7% of the responders). This may constitute an
extreme subset of this heterogenous condition and not the wider
picture. Furthermore, the ethnicity of respondents was not evaluated
and the pregnancy complications were not assessed. Never-the-less, no
association was found between maternal PCOS and PCOS
development among their adult daughters. The frequency of having a
PCOS affected mother among PCOS women was found to be relatively
low and similar to the frequency of having a PCOS mother among
unaffected daughters.
Several studies have suggested that high maternal testosterone levels
or maternal PCOS, were associated with low birth weight among
babies born [14,20,21]. However, other studies did not support those
findings [22,23]. Similarly, we found no significant differences between
the birth weights of female infants born to PCOS mothers and
controls.
As stated above, our stringent inclusion criteria may have excluded
the two thirds of respondent women as their symptoms where largely
un-confirmed and at the lower end of the spectrum of PCOS or
“PCOS-like” disease. However, the biochemical circumstantial
evidence is not strongly supportive of such a hypothesis of a large
subset of PCOS-Like symptoms due to in-utero androgen exposure:
during pregnancy, placental aromatase protects the fetus against
maternal androgens [24]. Impaired activity of this and other placental
enzymes has been postulated to potentially lead to fetal androgen
exposure [25] and placental post-maturity, arising as a result of
prolonged gestation, was hypothesized to be the most likely factor
leading to such enzymatic insufficiency [10]. A significantly higher
percentage of PCOS population were post-term (Chi-Square analysis:
p < 0.05; (Figure 2 and Table 1). However, the biological significance,
of this is unknown: Aromatase is a non-rate limiting enzyme,
conversion of androgens into estrogens is substrate rather than enzyme
dependent, and because of its placental abundance, even less than one
percent of normal placental levels is sufficient to protect against fetal
virilisation [26,27]. Therefore the hypotheses that aromatase capacity
maybe overwhelmed post-term by high androgen levels of maternal
origin, as a mechanism leading to preferentially susceptibility to
PCOS-like symptoms, is likely to be a rare rather than common event.
Significantly the mean BMI of PCOS daughters was statistically
higher (34.59 ± 9.35) in comparison to the control group (25.08 ± 6.74)
(Figure 3) which is in agreement with known obesity prevalence
among PCOS women [28]. However their BMI was not dependent on
having a PCOS neither affected mother nor related to their birth
weight, contrary to other studies [10].
Re-examination of the data from all respondents may show a
different correlation but this will have no validity power in confirmed
PCOS diagnosis and may be more a social “mother to daughter”
attitudinal identification of symptoms and behaviors. To firmly settle
the question of is there a familial associated in confirmed diagnosis of
PCOS in mothers and daughters is to recruit only PCOS patient who
are not overweight. This would require a repeat of this study but
aiming for 20,000 plus responses and an examination of a very small
minority of clinically confirmed PCOS in mothers who are non-obese
and neither are their adult daughters.
Although maternal hyperandrogenism during pregnancy has been
proposed to be a potential risk factor of PCOS among female offspring
[29,30]; our epidemiological study shows no familial association of
mother to daughter PCOS. Indeed, the only clearly pre-determining
factor to PCOS development is BMI. Thus, any such Maternal to
Daughter relationship in PCOS development must be considered in
light of socio-economic influence of being over-weight, rather than any
in-utero epigenetic molecular endocrine factors.
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